×
About 354 results

ALLMedicine™ Escherichia Coli Infections Center

Research & Reviews  171 results

Recent development in the design of small 'drug-like' and nanoscale glycomimetics again...
https://doi.org/10.1016/j.drudis.2021.02.025
Drug Discovery Today; Mousavifar L, Roy R

Mar 5th, 2021 - Glycoconjugates are involved in several pathological processes. Glycomimetics that can favorably emulate complex carbohydrate structures, while competing with natural ligands as inhibitors, are gaining considerable attention owing to their improve...

Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Em...
https://doi.org/10.1016/j.jpeds.2020.12.077
The Journal of Pediatrics; Lin CY, Xie J et. al.

Jan 8th, 2021 - To assess the performance of a hemolytic uremic syndrome (HUS) severity score among children with Shiga toxin-producing Escherichia coli (STEC) infections and HUS by stratifying them according to their risk of adverse events. The score has not bee...

Evaluation of the health and healthcare system burden due to antimicrobial-resistant Es...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726913
Antimicrobial Resistance and Infection Control; MacKinnon MC, Sargeant JM et. al.

Dec 11th, 2020 - Assessment of the burden of disease due to antimicrobial-resistant Escherichia coli infections facilitates understanding the scale of the problem and potential impacts, and comparison to other diseases, which allows prioritization of research, sur...

Activity of Tigecycline or Colistin in Combination with Zidovudine against Escherichia ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927862
Antimicrobial Agents and Chemotherapy; Zhou YF, Liu P et. al.

Oct 6th, 2020 - Alternative therapeutic options are urgently needed against multidrug-resistant Escherichia coli infections, especially in situations of preexisting tigecycline and colistin resistance. Here, we investigated synergistic activity of the antiretrovi...

Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy aft...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400587
International Journal of Environmental Research and Publi... Loconsole D, Giordano M et. al.

Jul 27th, 2020 - Shiga toxin-producing Escherichia coli (STEC) infections result in a significant public health impact because of the severity of the disease that, in young children especially, can lead to hemolytic-uremic syndrome (HUS). A rise in the number of H...

see more →

Guidelines  1 results

Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by ...
https://www.ncbi.nlm.nih.gov/pubmed/19834454
MMWR. Recommendations and Reports : Morbidity and Mortali... Gould LH, Bopp C et. al.

Oct 16th, 2009 - Shiga toxin--producing Escherichia coli (STEC) are a leading cause of bacterial enteric infections in the United States. Prompt, accurate diagnosis of STEC infection is important because appropriate treatment early in the course of infection might...

see more →

Clinicaltrials.gov  177 results

Recent development in the design of small 'drug-like' and nanoscale glycomimetics again...
https://doi.org/10.1016/j.drudis.2021.02.025
Drug Discovery Today; Mousavifar L, Roy R

Mar 5th, 2021 - Glycoconjugates are involved in several pathological processes. Glycomimetics that can favorably emulate complex carbohydrate structures, while competing with natural ligands as inhibitors, are gaining considerable attention owing to their improve...

Predicting Adverse Outcomes for Shiga Toxin-Producing Escherichia coli Infections in Em...
https://doi.org/10.1016/j.jpeds.2020.12.077
The Journal of Pediatrics; Lin CY, Xie J et. al.

Jan 8th, 2021 - To assess the performance of a hemolytic uremic syndrome (HUS) severity score among children with Shiga toxin-producing Escherichia coli (STEC) infections and HUS by stratifying them according to their risk of adverse events. The score has not bee...

Evaluation of the health and healthcare system burden due to antimicrobial-resistant Es...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726913
Antimicrobial Resistance and Infection Control; MacKinnon MC, Sargeant JM et. al.

Dec 11th, 2020 - Assessment of the burden of disease due to antimicrobial-resistant Escherichia coli infections facilitates understanding the scale of the problem and potential impacts, and comparison to other diseases, which allows prioritization of research, sur...

Activity of Tigecycline or Colistin in Combination with Zidovudine against Escherichia ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927862
Antimicrobial Agents and Chemotherapy; Zhou YF, Liu P et. al.

Oct 6th, 2020 - Alternative therapeutic options are urgently needed against multidrug-resistant Escherichia coli infections, especially in situations of preexisting tigecycline and colistin resistance. Here, we investigated synergistic activity of the antiretrovi...

Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy aft...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400587
International Journal of Environmental Research and Publi... Loconsole D, Giordano M et. al.

Jul 27th, 2020 - Shiga toxin-producing Escherichia coli (STEC) infections result in a significant public health impact because of the severity of the disease that, in young children especially, can lead to hemolytic-uremic syndrome (HUS). A rise in the number of H...

see more →

News  5 results

New Target in Sepsis: The Host Response
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/54884

Nov 25th, 2015 - Action Points As antibiotic resistance rises worldwide, researchers have been exploring novel ways to treat severe sepsis, with one group having discovered host-protective molecules that potentially could be harnessed to eradicate bacteria quickly...

ICEID: Data highlight biofilm role in waterborne illness
https://www.mdedge.com/pulmonary-health-hub/article/102642/infectious-diseases/iceid-data-highlight-biofilm-role-waterborne
Sharon Worcester

Sep 14th, 2015 - ATLANTA – Emerging biofilm-associated pathogens are overtaking those transmitted by the fecal-oral route as the most-common cause of death from waterborne illness in the United States, according to findings from a review of administrative and dise.

Duodenoscopes transmitted resistant E. coli to 39 patients
https://www.mdedge.com/gihepnews/article/87792/gastroenterology/duodenoscopes-transmitted-resistant-e-coli-39-patients
Mary Ann Moon, MDedge News

Oct 7th, 2014 - Contaminated duodenoscopes triggered a 2013 outbreak of a rare strain of Escherichia coli infections at a single hospital in northeastern Illinois, according to a report published online Oct. 7 in JAMA.

New FDA Orphan Drugs: CellCept, Prochymal, Shiga Toxin Antibodies
https://www.medscape.com/viewarticle/521133

Jan 8th, 2006 - Jan. 9, 2006 — The FDA has approved orphan drug status for mycophenolate mofetil for the treatment of myasthenia gravis; an adult stem cell product for the treatment of acute graft vs host disease; and 2 therapeutic monoclonal antibodies for the t...

International Approvals: Glucostrim, Aricept Evess, Shiga Toxin Antibodies
https://www.medscape.com/viewarticle/520787

Jan 2nd, 2006 - Jan. 3, 2006 — The Chinese Food and Drug Administration has approved qiyao capsules for adjunctive use in the treatment of type 2 diabetes; completion of the mutual recognition procedure has allowed use of donepezil HCl orally disintegrating table...

see more →